Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.2430
+0.0028 (1.17%)
Feb 13, 2026, 3:59 PM EST
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $383.25 million as of February 13, 2026. Its market cap has increased by 3.76% in one year.
Market Cap
383.25M
Enterprise Value
469.14M
Revenue
937.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.24
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 383.25M, an increase of 3,624.77%. That is a compound annual growth rate of 16.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 383.25M | 6.94% |
| Dec 31, 2025 | 358.39M | -1.53% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 308.63M |
| Silence Therapeutics | 210.19M |
| HST Global | 139.70M |
| Vaxart | 135.83M |
| BioStem Technologies | 97.44M |
| Nuo Therapeutics | 77.26M |
| Vicapsys Life Sciences | 48.56M |
| Arch Biopartners | 45.75M |